Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 8,521 $ 14,042
Accounts receivable 106 59
Inventory, current 446 488
Prepaid expenses and other current assets 737 781
Total current assets 9,810 15,370
Fixed assets, net 1,209 1,325
Inventory, non-current 377 511
Right-of-use assets 332 428
Other non-current assets 13 13
Total assets 11,741 17,647
Current liabilities:    
Current portion of long-term debt, net of unamortized debt discount of $151 and $182, respectively 2,694 2,532
Accounts payable and accrued expenses 1,470 1,969
Operating lease liabilities – current 243 245
Other current liabilities 44 53
Total current liabilities 4,451 4,799
Convertible note, net of unamortized debt discount of $80 and $108, respectively 3,920 3,892
Long-term debt, net of unamortized debt discount of $70 and $135, respectively 3,198 4,589
Contingent royalty obligation 1,056 1,212
Operating lease liabilities - non-current 79 178
Total liabilities 12,704 14,670
Commitments and contingent liabilities (Note 9)
Shareholders’ (deficiency) equity    
Common stock $0.0001 par value; 115,000,000 shares authorized; 5,305,441 and 4,659,769 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 1
Additional paid-in capital 147,770 144,328
Accumulated deficit (148,734) (141,351)
Total shareholders’ (deficiency) equity (963) 2,977
Total liabilities and shareholders’ (deficiency) equity $ 11,741 $ 17,647